课题基金 / 基金详情

MECHANISM OF THROMBIN RECEPTOR ACTIVATION DEACTIVATION

MECHANISM OF THROMBIN RECEPTOR ACTIVATION DEACTIVATION
凝血酶受体激活和失活机制
批准号:
6345230
负责人:
ATHAN KULIOPULOS
金额:
$0.38万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-07-01 至 2002-06-30

项目摘要

项目成果

ATHAN KULIOPULOS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
My lab is interested in the structure and function of f-actin binding proteins. We arecurrently determining the structure of the "headpiece" domain of the f-actin bundfing protein villin by NMR and X-ray crystallography. We have expressed a series of mutants of headpiece in E. coli and require mass spectral analysis to insure the product that we purify is the correct sequence and has not been modified during purification. Recently, we have developed conditions where we can reproducibly get crystals of headpiece that diffiract well in the X-ray beam (to beyond 1.8 A resolution). In order to the obtain phase information necessary to solve the high resolution X-ray crystal structure of villin headpiece, we turned to the multiple anomolous dispersion (MAD) method. MAD phasing requires data to be collected at a synchrotron source with headpiece derivatives labeled with selenomethionine. Data collection time at the Brookhaven Synchrotron Source is limited and must be applied for. Therefore, it was essential to have our selenium-labeled crystal prepared and characterized in advance. Is was important for us to insure that our labeling was effective and, in addition, that the selenium was not oxidized or lost during thepurification, before our visit to the synchrotron. The mass spectral analysis performed by the center was critical in insuring our crystal contained the expected selenium and was therefore suitable for synchrotron data collection and MAD phasing. No other method is as effective as mass spectral analysis in providing proof of the presence and percent occupancy of the selenium in our protein crystals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Metabolic Reprogramming by Protease-activated Receptor 2
  • 批准号:
    10365793
  • 项目类别:
  • 资助金额:
    $58.74万
  • 财政年份:
    2022
  • 负责人:
    ATHAN KULIOPULOS
  • 依托单位:
Metabolic Reprogramming by Protease-activated Receptor 2
  • 批准号:
    10569593
  • 项目类别:
  • 资助金额:
    $59.13万
  • 财政年份:
    2022
  • 负责人:
    ATHAN KULIOPULOS
  • 依托单位:
Matrix Metalloprotease-PAR1 Regulation of Atherosclerosis
  • 批准号:
    10064145
  • 项目类别:
  • 资助金额:
    $64.61万
  • 财政年份:
    2017
  • 负责人:
    ATHAN KULIOPULOS
  • 依托单位:
TRIP-PCI: PAR1 Pepducin-Based Interventions in Arterial Thrombosis
  • 批准号:
    8475397
  • 项目类别:
  • 资助金额:
    $205.58万
  • 财政年份:
    2012
  • 负责人:
    ATHAN KULIOPULOS
  • 依托单位:
海外基金